News Focus
News Focus
icon url

Bourbon_on_my_cornflakes

06/10/25 2:56 PM

#491530 RE: boi568 #491517

I asked your question #1 also. Too bad no answers given.
Also asked about reviving Rett.
And to name the "rare" disease.
As well as why it takes so long for AVXL to do anything.
icon url

BIOChecker4

06/10/25 8:47 PM

#491562 RE: boi568 #491517

Your questions are spot on, which is exactly why Missling chose not to engage with shareholders. Unlike the remaining covering analysts who throw softballs and try to suck up to Missling by congratulating him on a great quarter and all the progress even when there is little of either, real shareholders actually have hard but fair questions that would put Missling on the spot. Since he obviously puts absolutely no effort into anticipating questions and formulating and practicing answers in advance with his IR people and lawyers, no one should be surprised by his avoidance behavior.

Whatever the merits (or lack thereof) of Blarcamesine, the CEO remains the stock’s biggest liability resulting what I have long called the Missling Discount.